Previous 10 | Next 10 |
Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021 IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medic...
Targets FDA Submission IRVINE, CA / ACCESSWIRE / February 24, 2021 / Odyssey Group International, Inc. ( OTCQB:ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce that its coll...
Pre-clinical data for PRV-002, a nasally delivered drug in development for treating concussion, highlight rapid brain bioavailability IRVINE, CA / ACCESSWIRE / February 17, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a technology and asset acquisition company fo...
IRVINE, CA / ACCESSWIRE / February 9, 2021 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce multiple recent television segments focuse...
Provides Safer and Faster Access to the Brain IRVINE, CA / ACCESSWIRE / January 26, 2021 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to ...
Stability Temperatures Ideal for Transportation and Storage, Suitable for Sports Playing Fields and Military Operations IRVINE, CA / ACCESSWIRE / January 20, 2021 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company ...
All Stock Transaction Phase 1 Clinical Trial Site, Protocol and CRO Established IRVINE, CA / ACCESSWIRE / January 11, 2021 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the “Company” or “Odyssey”), a technology and asset acquisition co...
Promising Test Results Leads to Design Improvements IRVINE, CA / ACCESSWIRE / December 16, 2020 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is plea...
Company Continues to Advance Product Development Programs IRVINE, CA / ACCESSWIRE / December 7, 2020 / Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
News, Short Squeeze, Breakout and More Instantly...
Odyssey Group International Inc Company Name:
ODYY Stock Symbol:
OTCMKTS Market:
Odyssey Group International Inc Website:
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) , formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medical products, recently filed its quarterly report for the quarter ended January 31, 2024. The ...
LAS VEGAS, NV / ACCESSWIRE / January 2, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) ("Odyssey" or the "Company") today announces the closing of the definitive Asset Purchase Agreement, that was entered into on October 4, 2023, with Oragenics, Inc., (OGEN:NYSE American) under which Oragenics acquire...
LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. ( OTCOB:ODYY ), a company focused on developing unique, life-enhancing medical products including a drug treatment intended to treat concussion, announces that it has received stockholder approval for the sale of its neurologi...